(Q43723795)

English

Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis (English)

1 reference

Europe PubMed Central

26 November 2017

1 reference

based on heuristic

inferred from title

3

object named as

Sobel JD

1 reference

Europe PubMed Central

26 November 2017

author name string

Vazquez JA

1

1 reference

Europe PubMed Central

26 November 2017

Peng G

2

1 reference

Europe PubMed Central

26 November 2017

Steele-Moore L

4

1 reference

Europe PubMed Central

26 November 2017

Schuman P

5

1 reference

Europe PubMed Central

26 November 2017

Holloway W

6

1 reference

Europe PubMed Central

26 November 2017

Neaton JD

7

1 reference

Europe PubMed Central

26 November 2017

language of work or name

0 references

publication date

5 September 2001

1 reference

Europe PubMed Central

26 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

26 November 2017

33

1 reference

Europe PubMed Central

26 November 2017

1069-1075

1 reference

Europe PubMed Central

26 November 2017

7

1 reference

Europe PubMed Central

26 November 2017

Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Fungal infections in patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Multiple intravenous dose pharmacokinetic study of carumonam in healthy subjects

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Fluconazole-resistant Candida albicans

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses stu

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1086%2F322641

21 January 2018

Identifiers

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43723795&oldid=2102847884"